Zibing Wang

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 3

Top Topics

Patient Reported Outcomes

Peritoneal Dialysis

Ejection Fraction

Small Cell Lung Cancer

Top Venues

Cancer immunology, immunotherapy : CII

Cancer gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Zibing Wang, Yuqing Liu, Ling Peng, Brian Till, Yuwei Liao, Shumin Yuan, Xiang Yan, Lin Chen, Qiang Fu, Zhihai Qin
Role of fibrosarcoma-induced CD11b + myeloid cells and tumor necrosis factor-α in B cell responses. Oncogene 41 (10) (2022)
Shumin Yuan, Ling Peng, Yuqing Liu, Brian G Till, Xiang Yan, Jie Zhang, Liping Zhu, Huijuan Wang, Shaokai Zhang, Hongle Li, Quanli Gao, Zibing Wang
Low-dose anlotinib confers improved survival in combination with immune checkpoint inhibitor in advanced non-small cell lung cancer patients. Cancer immunology, immunotherapy : CII (2022)
Zhiqiang Wang, Liping Zhu, Li Li, Justin Stebbing, Zibing Wang, Ling Peng
Identification of an immune gene-associated prognostic signature in patients with bladder cancer. Cancer gene therapy 29 (5) (2022)